Ex vivo comparison of ACU193 and lecanemab reveals binding differences in mouse brain.
Saved in:
| Title: | Ex vivo comparison of ACU193 and lecanemab reveals binding differences in mouse brain. |
|---|---|
| Authors: | Grenon MB; Building for Transformative Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands., Cline EN; Acumen Pharmaceuticals, Newton, Massachusetts, USA., Jerecic J; Acumen Pharmaceuticals, Newton, Massachusetts, USA., Johnson E; Acumen Pharmaceuticals, Newton, Massachusetts, USA., Siemers E; Acumen Pharmaceuticals, Newton, Massachusetts, USA., Lemere CA; Building for Transformative Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA. |
| Source: | Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2026 Jun; Vol. 22 (6), pp. e71509. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-5279 |
|---|---|
| DOI: | 10.1002/alz.71509 |
